Vento S, Garofano T, Renzini C, Casali F, Ferraro T, Concia
E.  Enhancement of hepatitis C virus replication and liver
damage in  HIV-coinfected patients on antiretroviral
combination therapy.  AIDS 12(1):116-117 (Jan 1998).

Page 117: In conclusion, widely employed antiretroviral
combination  therapies appear to have no beneficial effect
on the course of  HCV-induced chronic liver disease in
HIV-infected asymptomatic  patients. In contrast, treatment
seems to initially increase HCV  replication and liver
damage and can decompensate liver function.  However,
discontinuation of therapy seems to be warranted in only a
minority of patients with severe chronic hepatitis, because
continuing  treatment is associated with a subsequent, slow,
progressive reduction  in HCV RNA and aminotransferase
concentrations towards pre-treatment  levels.